Resilience

Photo
12.06.2025 • NewsPharma

Resilience Will Close 6 of its 10 Plants

Resilience recently shared that capacity expansions have exceeded current industry demand. As a result, Resilience has begun consolidating its operations and streamlining its business strategy.

Photo
17.01.2023 • News

Resilience and Mubadala in Biopharma Venture

US biopharma manufacturing and technology company National Resilience has entered into an agreement with Abu Dhabi investor Mubadala Investment Company to build a manufacturing plant in the United Arab Emirate’s biggest city. This will be the first GMP biopharma facility in the UAE.

Photo
07.12.2022 • NewsInnovation

Chemistry and the „Next Normal”

Numerous crises such as climate change, energy shortages, raw material shortages, war in Ukraine and the consequences of the pandemic are putting value chains worldwide to the test.

Photo
01.12.2022 • News

AstraZeneca Boosts Cancer Portfolio with Neogene Buy

AstraZeneca has agreed to acquire Neogene Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and manufacture of next-generation T-cell receptor therapies (TCR-Ts) – a promising and novel cell therapy approach to target cancer.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.